Cargando…
Screening of Potential Biomarkers for Gastric Cancer with Diagnostic Value Using Label-free Global Proteome Analysis
Gastric cancer (GC) is known as a top malignant type of tumors worldwide. Despite the recent decrease in mortality rates, the prognosis remains poor. Therefore, it is necessary to find novel biomarkers with early diagnostic value for GC. In this study, we present a large-scale proteomic analysis of...
Autores principales: | Song, Yongxi, Wang, Jun, Sun, Jingxu, Chen, Xiaowan, Shi, Jinxin, Wu, Zhonghua, Yu, Dehao, Zhang, Fei, Wang, Zhenning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377014/ https://www.ncbi.nlm.nih.gov/pubmed/33607292 http://dx.doi.org/10.1016/j.gpb.2020.06.012 |
Ejemplares similares
-
Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis
por: Wu, Zhonghua, et al.
Publicado: (2017) -
Quantitative global proteome and lysine succinylome analyses provide insights into metabolic regulation and lymph node metastasis in gastric cancer
por: Song, Yongxi, et al.
Publicado: (2017) -
MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer
por: Shi, Jinxin, et al.
Publicado: (2021) -
Prognostic value of gastric cancer‐associated gene signatures: Evidence based on a meta‐analysis using integrated bioinformatics methods
por: Wang, Jun, et al.
Publicado: (2018) -
Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer
por: Ma, Bin, et al.
Publicado: (2016)